Eric Burks

ORCID: 0000-0002-3122-2875
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Lung Cancer Treatments and Mutations
  • Medical Imaging and Pathology Studies
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Urological Disorders and Treatments
  • Genital Health and Disease
  • Bladder and Urothelial Cancer Treatments
  • MicroRNA in disease regulation
  • Cardiac tumors and thrombi
  • AI in cancer detection
  • Sarcoma Diagnosis and Treatment
  • Ferroptosis and cancer prognosis
  • Urologic and reproductive health conditions
  • Renal and related cancers
  • Liver Disease Diagnosis and Treatment
  • Epigenetics and DNA Methylation
  • IgG4-Related and Inflammatory Diseases
  • Renal cell carcinoma treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • Urinary and Genital Oncology Studies
  • Cervical Cancer and HPV Research
  • Gene expression and cancer classification

Boston University
2020-2025

Boston Medical Center
2019-2024

Lahey Hospital and Medical Center
2012-2024

Universidad Libre de Colombia
2022

University of Minnesota Rochester
2022

Gangneung Asan Hospital
2022

MSD K.K. (Japan)
2021-2022

Novartis (Switzerland)
2022

American Society for Radiation Oncology
2022

Jazz Pharmaceuticals (United States)
2022

Adam Abeshouse Jaeil Ahn Rehan Akbani Adrian Ally Samirkumar B. Amin and 95 more Chris Andry Matti Annala Armen Aprikian Joshua Armenia Arshi Arora J. Todd Auman Miruna Balasundaram Saianand Balu Christopher E. Barbieri Thomas Bauer Christopher C. Benz Alain Bergeron Rameen Beroukhim Mario Berríos Adrian Bivol Tom Bodenheimer Lori Boice Arnoud Boot Rodolfo Borges dos Reis Paul C. Boutros Jay Bowen Reanne Bowlby Jeffrey M. Boyd Robert K. Bradley Anne Breggia Fadi Brimo Christopher A. Bristow Denise Brooks Bradley M. Broom Alan H. Bryce Glenn J. Bubley Eric Burks Yaron S.N. Butterfield M. Button David Canes Carlos Gilberto Carlotti Rebecca Carlsen Michel Carmel Peter R. Carroll Scott L. Carter Richard W. Cartun Brett S. Carver June M. Chan Matthew T. Chang Yu Chen Andrew D. Cherniack Simone Chevalier Lynda Chin Juok Cho Andy Chu Eric Chuah Sudha Chudamani Kristian Cibulskis Giovanni Ciriello Amanda Clarke Matthew R. Cooperberg Niall M. Corcoran Anthony J. Costello Janet E. Cowan Daniel Crain Erin Curley Kerstin A. David John A. Demchok Francesca Demichelis Noreen Dhalla Rajiv Dhir Alexandre A. Doueik Bettina F. Drake Heidi Dvinge Natalya Dyakova Ina Felau Martin L. Ferguson Scott Frazer Stephen J. Freedland Yao Fu Stacey Gabriel Jianjiong Gao Johanna Gardner Julie M. Gastier-Foster Nils Gehlenborg Mark Gerken Mark Gerstein Gad Getz Andrew K. Godwin Anuradha Gopalan Markus Graefen Kiley Graim Thomas Gribbin Ranabir Guin Manaswi Gupta Angela Hadjipanayis Syed Haider Lucie Hamel D. Neil Hayes David I. Heiman

10.1016/j.cell.2015.10.025 article EN publisher-specific-oa Cell 2015-11-01
A. Gordon Robertson Jaegil Kim Hikmat Al‐Ahmadie Joaquim Bellmunt Guangwu Guo and 95 more Andrew D. Cherniack Toshinori Hinoue Peter W. Laird Katherine A. Hoadley Rehan Akbani Mauro A. A. Castro Ewan A. Gibb Rupa S. Kanchi Dmitry A. Gordenin Sachet A. Shukla Francisco Sánchez-Vega Donna E. Hansel Bogdan Czerniak Victor E. Reuter Xiaoping Su Benílton de Sá Carvalho Vinicius S Chagas Karen Mungall Sara Sadeghi Chandra Sekhar Pedamallu Yiling Lu Leszek J. Klimczak Jiexin Zhang Caleb Choo Akinyemi I. Ojesina Susan Bullman Kristen Leraas Tara M. Lichtenberg Catherine J. Wu N. Schultz Gad Getz Matthew Meyerson Gordon B. Mills David J. McConkey John N. Weinstein David J. Kwiatkowski Seth P. Lerner Rehan Akbani Hikmat Al‐Ahmadie Monique Albert Iakovina Alexopoulou Adrian Ally Tatjana Antic Manju Aron Miruna Balasundaram John M.S. Bartlett Stephen B. Baylin Allison Beaver Joaquim Bellmunt İnanç Birol Lori Boice Arnoud Boot Jay Bowen Reanne Bowlby Denise Brooks Bradley M. Broom Wiam Bshara Susan Bullman Eric Burks Flavio Mavignier Cárcano Rebecca Carlsen Benilton S. Carvalho André Lopes Carvalho Eric Castle Mauro A. A. Castro Mauro A. A. Castro James W.F. Catto Vinicius S Chagas Andrew D. Cherniack David Chesla Caleb Choo Eric Chuah Sudha Chudamani Victoria K. Cortessis Sandra Cottingham Daniel Crain Erin Curley Bogdan Czerniak Siamak Daneshmand John A. Demchok Noreen Dhalla Hooman Djaladat John Eckman Sophie Egea Jay Engel Ina Felau Martin L. Ferguson Johanna Gardner Julie M. Gastier‐Foster Mark Gerken Gad Getz Ewan A. Gibb Carmen Gomez‐Fernandez Dmitry A. Gordenin Guangwu Guo

10.1016/j.cell.2017.09.007 article EN publisher-specific-oa Cell 2017-10-01
Michael A. Gillette Shankha Satpathy Song Cao Saravana M. Dhanasekaran Suhas Vasaikar and 95 more Karsten Krug Francesca Petralia Yize Li Wen-Wei Liang Boris Reva Azra Krek Jiayi Ji Xiaoyu Song Wenke Liu Runyu Hong Lijun Yao Lili M. Blumenberg Sara R. Savage Michael C. Wendl Bo Wen Kai Li Lauren C. Tang Melanie A. MacMullan Shayan C. Avanessian M. Harry Kane Chelsea J. Newton MacIntosh Cornwell Ramani Kothadia Weiping Ma Seungyeul Yoo Rahul Mannan Pankaj Vats Chandan Kumar‐Sinha Emily Kawaler Tatiana Omelchenko Antonio Colaprico Yifat Geffen Yosef E. Maruvka Felipe da Veiga Leprevost Maciej Wiznerowicz Zeynep H. Gümüş Rajwanth Veluswamy Galen Hostetter David I. Heiman Matthew A. Wyczalkowski Tara Hiltke Mehdi Mesri Christopher R. Kinsinger Emily S. Boja Gilbert S. Omenn Arul M. Chinnaiyan Henry Rodriguez Qing Kay Li Scott D. Jewell Mathangi Thiagarajan Gad Getz Bing Zhang David Fenyö Kelly V. Ruggles Marcin Cieślik Ana I. Robles Karl R. Clauser Ramaswamy Govindan Pei Wang Alexey I. Nesvizhskii Li Ding D.R. Mani Steven A. Carr Alex Webster Alicia Francis Alyssa Charamut Amanda G. Paulovich Amy M. Perou Andrew K. Godwin Andrii Karnuta Annette Marrero-Oliveras Barbara Hindenach Barbara L. Pruetz Bartosz Kubisa Brian J. Druker Chet Birger Corbin D. Jones Dana R. Valley Daniel C. Rohrer Daniel Cui Zhou Daniel W. Chan David Chesla David Clark Dmitry Rykunov Donghui Tan Elena V. Ponomareva Elizabeth R. Duffy Eric Burks Eric E. Schadt Erik J. Bergstrom Eugene S. Fedorov Ewa P. Malc George D. Wilson Haiquan Chen Halina Krzystek

To explore the biology of lung adenocarcinoma (LUAD) and identify new therapeutic opportunities, we performed comprehensive proteogenomic characterization 110 tumors 101 matched normal adjacent tissues (NATs) incorporating genomics, epigenomics, deep-scale proteomics, phosphoproteomics, acetylproteomics. Multi-omics clustering revealed four subgroups defined by key driver mutations, country, gender. Proteomic phosphoproteomic data illuminated downstream copy number aberrations, somatic...

10.1016/j.cell.2020.06.013 article EN cc-by-nc-nd Cell 2020-07-01
Shankha Satpathy Karsten Krug Pierre M. Jean Beltran Sara R. Savage Francesca Petralia and 95 more Chandan Kumar‐Sinha Yongchao Dou Boris Reva M. Harry Kane Shayan C. Avanessian Suhas Vasaikar Azra Krek Jonathan T. Lei Eric J. Jaehnig Tatiana Omelchenko Yifat Geffen Erik J. Bergstrom Vasileios Stathias Karen E. Christianson David I. Heiman Marcin Cieślik Song Cao Xiaoyu Song Jiayi Ji Wenke Liu Kai Li Bo Wen Yize Li Zeynep H. Gümüş Myvizhi Esai Selvan Rama Soundararajan Tanvi H. Visal Maria Gabriela Raso Edwin R. Parra Özgün Babur Pankaj Vats Shankara Anand Tobias Schraink MacIntosh Cornwell Fernanda Martins Rodrigues Houxiang Zhu Chia-Kuei Mo Yuping Zhang Felipe da Veiga Leprevost Chen Huang Arul M. Chinnaiyan Matthew A. Wyczalkowski Gilbert S. Omenn Chelsea J. Newton Stephan C. Schürer Kelly V. Ruggles David Fenyö Scott D. Jewell Mathangi Thiagarajan Mehdi Mesri Henry Rodriguez Sendurai A. Mani Namrata D. Udeshi Gad Getz James Suh Qing Kay Li Galen Hostetter Paul K. Paik Saravana M. Dhanasekaran Ramaswamy Govindan Li Ding Ana I. Robles Karl R. Clauser Alexey I. Nesvizhskii Pei Wang Steven A. Carr Bing Zhang D.R. Mani Michael A. Gillette Alexander L. Green Alfredo Molinolo Alicia Francis Amanda G. Paulovich Andrii Karnuta Antonio Colaprico Barbara Hindenach Barbara L. Pruetz Bartosz Kubisa Brian J. Druker Carissa A. Huynh Charles A. Goldthwaite Chet Birger Christopher R. Kinsinger Corbin D. Jones Dan Rohrer Dana R. Valley Daniel W. Chan David Chesla Donna E. Hansel Elena V. Ponomareva Elizabeth R. Duffy Eric Burks Eric E. Schadt Eugene S. Fedorov Eunkyung An

Lung squamous cell carcinoma (LSCC) remains a leading cause of cancer death with few therapeutic options. We characterized the proteogenomic landscape LSCC, providing deeper exposition LSCC biology potential implications. identify NSD3 as an alternative driver in FGFR1-amplified tumors and low-p63 overexpressing target survivin. SOX2 is considered undruggable, but our analyses provide rationale for exploring chromatin modifiers such LSD1 EZH2 to SOX2-overexpressing tumors. Our data support...

10.1016/j.cell.2021.07.016 article EN cc-by-nc-nd Cell 2021-08-01

Deep learning is a powerful tool for whole slide image (WSI) analysis. Typically, when performing supervised deep learning, WSI divided into small patches, trained and the outcomes are aggregated to estimate disease grade. However, patch-based methods introduce label noise during training by assuming that each patch independent with same as neglect overall WSI-level information significant in grading. Here we present Graph-Transformer (GT) fuses graph-based representation of an vision...

10.1109/tmi.2022.3176598 article EN cc-by IEEE Transactions on Medical Imaging 2022-05-20

Abstract Objectives A subset of coronavirus disease 2019 (COVID-19) patients exhibit clinical features cytokine storm. However, clinicopathologic diagnostic hemophagocytic lymphohistiocytosis (HLH) have not been reported. We studied the reticuloendothelial organs 4 consecutive who died COVID-19 and correlated with laboratory parameters to detect HLH. Methods Autopsies were performed on COVID-19. Routine H&E staining immunohistochemical for CD163 hemophagocytosis. Clinical results from...

10.1093/ajcp/aqaa124 article EN other-oa American Journal of Clinical Pathology 2020-07-06

Despite achieving a hematologic complete response after treatment, many patients with AL amyloidosis do not attain recovery of organ function and/or experience relapse. A persistent plasma cell clone producing amyloidogenic light chains at levels below the detection threshold traditional serologic methods is hypothesized to impede in some patients. Assessment minimal residual disease (MRD) may therefore have clinical importance as more stringent treatment tool for response. We used 2-tube,...

10.1182/bloodadvances.2019001331 article EN cc-by-nc-nd Blood Advances 2020-03-04

SARS-CoV-2 infection disturbs the coagulation balance in blood, triggering thrombosis and contributing to organ failure. The role of prothrombotic metabolites COVID-19-associated coagulopathy remains elusive. Leveraging K18-hACE2 mice infected with SARS-CoV-2, we observed higher levels tryptophan metabolite, kynurenine, compared controls. SARS CoV-2 showed a significant upregulation enzymes controlling Kynurenine biogenesis, such as indoleamine 2,3-dioxygenase (IDO-1) kidneys liver,...

10.1101/2025.01.17.633602 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2025-01-21

ABSTRACT The molecular drivers bronchial premalignant lesion progression to invasive lung squamous cell carcinoma are not well defined. Prior work profiling longitudinally collected biopsies by RNA sequencing defined a proliferative subtype, enriched with dysplasia. We found that gene co-expression module associated interferon gamma signaling and antigen processing/presentation was down-regulated in progressive/persistent versus regressive lesions within the suggesting functional impact of...

10.1101/2025.02.03.636307 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2025-02-05

CD4(+) CD56(+) lineage-negative malignancies are difficult to diagnose and classify. Recent studies have suggested that these may derive from plasmacytoid dendritic cells (pDC). In this report, we examine 10 cases of CD4+, CD56+ presented in various tissue sites. The goal was identify the morphologic, immunophenotypic, genotypic findings devise a diagnostic approach biopsies lesions confirm proposed cell origin. mean age 66 years (range, 45-80 years) with male predominance (8 males/2...

10.1097/01.pas.0000172194.32918.5c article EN The American Journal of Surgical Pathology 2005-09-13

Inflammatory myofibroblastic tumors (IMT) of the uterus may be underrecognized as their morphology and immunophenotype overlap with myxoid variants uterine smooth muscle endometrial stromal tumors. Although ALK is a helpful biomarker, not all IMTs are -rearranged, small subset leiomyosarcomas ALK-positive. Herein, we evaluated series 23 for novel markers interferon-inducible transmembrane protein-1 (IFITM1) BCOR, myoid marker transgelin, possible predictive p16 p53 by immunohistochemistry to...

10.1097/pas.0000000000001525 article EN The American Journal of Surgical Pathology 2020-06-19

Objective To identify micro RNA (mi ) characteristic of metastatic clear cell renal carcinoma (cc RCC and those indicative cancer‐specific survival ( CSS in nephrectomy biopsy specimens. We also sought to determine if a mi panel could differentiate benign from cc tissue. Materials Methods was isolated kidney specimens n = 156 46, respectively). Samples were grouped: benign, non‐progressive, progressive . Mi s profiled by microarray validated quantitative reverse transcription‐polymerase...

10.1111/bju.13886 article EN BJU International 2017-04-22

The most severe and fatal infections with SARS-CoV-2 result in the acute respiratory distress syndrome, a clinical phenotype of coronavirus disease 2019 (COVID-19) that is associated virions targeting epithelium distal lung, particularly facultative progenitors this tissue, alveolar epithelial type 2 cells (AT2s). Little known about initial responses human lung alveoli to infection due part inability access these from patients, at early stages disease. Here we present an vitro model...

10.1101/2020.06.30.175695 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-06-30

Abstract Background A subset of COVID-19 patients exhibit clinical features cytokine storm. However, clinicopathologic diagnostic hemophagocytic lymphohistiocytosis (HLH) have not been reported. Pathologic studies to date largely focused on the pulmonary finding diffuse alveolar damage (DAD). To this aim, we study reticuloendothelial organs four consecutive dying and correlate with laboratory parameters detect HLH. Methods Autopsies restricted chest abdomen were performed who succumbed...

10.1101/2020.05.07.20094888 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-05-12

Recent randomized control trials (JCOG0802 and CALGB140503) have shown sublobar resection to be noninferior lobectomy for non-small cell lung cancer (NSCLC) ≤2.0 cm. We previously proposed histologic criteria stratifying adenocarcinoma into indolent low malignant potential (LMP) aggressive angioinvasive adenocarcinomas, resulting in better prognostication than provided by World Health Organization grade. Here we determine whether pathologic classification is reproducible subsets of...

10.1016/j.xjon.2023.11.003 article EN cc-by-nc-nd JTCVS Open 2023-11-13

Lung cancer screening has improved mortality among high-risk smokers but coincidentally detected a fraction of nonprogressive adenocarcinoma historically classified as bronchoalveolar carcinoma (BAC). In the National Screening Trial (NLST) majority BAC—comprising 29% computed tomography–detected stage I lung adenocarcinoma—were considered overdiagnosis after extended follow-up comparison with control arm. current classification, in situ and minimally invasive have replaced BAC together...

10.1097/pas.0000000000001618 article EN The American Journal of Surgical Pathology 2020-11-10
Coming Soon ...